IL6 and cancer: In both cancers, gastric and esophagus, IL-32 upregulation was coupregulated with proinflammatory cytokines such as TNF-α, IL-1β, and IL-6, suggesting its induction via NF-κB and STAT3 signaling pathways was linked to poor-prognosis cases.